Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05262556
Title TQ (Thymoquione) Formula With Nivolumab and Ipilimumab in Gastroenteropancreatic Neuroendocrine Carcinomas
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Amr Mohamed MD
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland Ohio 44106 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field